INTRODUCTION
Clathrin-coated vesicles are dynamic intracellular organelles involved in endocytosis. Two main transport pathways mediated via clathrin-coated vesicles are recognized. One directs vesicles from the plasma membrane to the lysosomes and the second transports vesicles from the trans-Golgi network to the lysosomes or to the plasma membrane. Clathrin is a major protein component of these structures and its role is to promote formation of clathrin-coated pits and clathrin-coated vesicles (for review refs 1,2). Two types of clathrin light chain genes have been described (3) (4) (5) . To date, only single clathrin heavy chain genes were cloned in R. norvegicus (6) , S. cerevisiae (7) , H. sapiens (8, 9) , D. discoideum (10) , D. melanogaster (11) , and B. taurus (12) .
We report the cloning and characterization of the second human clathrin heavy chain gene (CLH-22) from chromosome 22q11. Also, in this issue of Human Molecular Genetics (pp. 617-624) another group reports cloning of apparently the same gene (13) . Here we extend the finding of Sirotkin et al. (13) by showing that the gene is alternatively spliced and highly expressed in skeletal muscle, testis and heart. In addition, our Northern and Southern blot analysis of meningiomas clearly suggests that this gene may be involved in the tumorigenesis and can be considered as a candidate for a tumor suppressor.
RESULTS

Cloning, sequencing, and mapping of the clathrin heavy chain gene from chromosome 22q11 and its comparison with related genes
The gene was cloned using the so called 'software-based exon-trapping' approach based on the availability of genomic sequence combined with use of exon prediction computer programs. In the course of transcriptional characterization of several regions on human chromosome 22, we selected numerous cosmid clones for large scale genomic sequencing. Among these, cosmid E75F1 mapping to the vicinity of the telomere of 22q was partially sequenced. At present, it consists of 13 sequence contigs ranging from 1 to 11 kb spanning over 48 kbp. Partial sequence of E75F1 was used for exon prediction (using the grail program) (14) , as well as for database searches. One of the contigs, number 464 (1116 bp, Fig. 1, A2 ), which could not be joined or related to the rest of the sequencing project, produced one 147 bp *To whom correspondence should be addressed Summary of positions and lengths of 10 additional cDNA clones isolated from three different libraries: cfb, cam, and cfm denote human foetal brain (polyT+ random primed), human adult muscle (polyA primed) and human foetal muscle (polyT+ random primed) cDNA libraries, respectively. 'cfb.4' clone is the only clone isolated from the human foetal brain cDNA library by the PCR fragment amplified from cosmid E75F1 (see above A2 and text). This clone contains EcoRI site, which was used for excision of the insert in two distinct fragments, cfb4A and cfb4B. presumptive exon, scored as 'excellent' and with high similarity at the protein level to members of clathrin heavy chain (CLH) polypeptides (data not shown). Further FastA searches in the EMBL/GenBank database using contig 464, filtered by the PYTHIA repetitive DNA sequence server, showed 74.4% identity with rat CLH (accession no. J03583), 72.7% with randomly sequenced human cDNA corresponding to CLH from chromosome 17 (accession no. D21260) and 72.5% identity with partial human CLH (accession no. X55878), respectively. A PCR-derived probe, called 75L (374 bp), encompassing the presumptive 147 bp exon was generated and used for screening of a human foetal brain cDNA library (Fig. 1, A2 ). One clone was found after screening of ∼600 000 phage clones (termed cfb4, Fig.  1B ). The DNA sequence of its 4.5 kbp insert was determined using a combined shot-gun and primer walking strategy. Inserts of 2 shot-gun sequencing subclones, one from the 5′ and one from the 3′ end of cfb4 were used as probes for further full-length cDNA screening. Two skeletal muscle cDNA libraries (adult and foetal) were chosen for these experiments, based on results from Northern blot analysis using clone cfb4 ( Fig. 2 and below) . Our cDNA screening results are summarized in Figure 1B . Twentyfour cDNA clones were isolated and sequenced at least using vector-derived primers on both sides flanking the inserts. A 5470 bp of cDNA sequence covering the entire open reading frame of the gene, capable of encoding 1640 amino acids was obtained. Our sequence encompasses the whole 3′ untranslated part of the transcript and ends with a polyA tail. Based on the results from Northern blot analysis ( Fig. 3 and below) , the estimated CLH-22 transcript size is 6 kb. Thus, ∼500-600 bp of the 5′ untranslated part can be estimated to be missing. This cDNA has been sequenced at least once on both strands throughout its 5470 bp. The cDNA sequencing project consists of 270 independent gel readings generated on the ABI (Applied Biosystems, Inc.) 373A sequencer, and reached an average redundancy of over 10 gel characters per consensus character.
We used the cDNA clone cfb4 to confirm the chromosomal localization of the gene by hybridization screening of two human chromosome 22-specific cosmid libraries. In total 31 cosmid clones were identified in this screen (E-number and N-number indicate clones from LL22NC01 and LL22NC03 libraries, respectively: E89H1, E91B1, E98A3, E104E7, E106A4, E127G3, E127G8, E128E7, E131F1, E132G3, E133E3, E144F9, N5D9, N15A10, N20D7, N20D8, N24G1, N37E11, N56C2, N59C10, N64E5, N79H12, N81C11, N91E3, N97F5, N98B11, N98G4, N110G7, N115C5, N127G9, N128F2 and N130B10). Surprisingly, neither E75F1 nor any other of the neighboring cosmids in the cosmid contig covering a part of 22q13 were recognized by this cDNA. In order to further confirm our results, Figure 2 . Comparison of the two human clathrin heavy chain polypeptides. CLH-22 and CLH-17 denote the clathrins from chromosome 22 and 17, respectively. Black boxes display regions of amino acid identity between the proteins. Shaded boxes show regions of similarity (conservative amino acid changes) and white boxes represent non-conservative amino acid substitutions. The overall identity and similarity between these two proteins is 84.7 and 91.1%, respectively. At the nucleic acid level, identity between ORF of both genes is 74.3%.
we performed hybridization screening of the cosmid libraries using the probe 75L, with similar negative results as was the case for cfb4 cDNA clone. We also failed to PCR-amplify the fragment 75L using a newly prepared DNA from the cosmid E75F1 straight from the cosmid library. Based on this, we conclude that DNA used for sequencing of cosmid E75F1 must have been contaminated with other DNA.
Using available YAC contig for human chromosome 22 (15) we were able to map this gene to the 22q11 region. The clone cfb4 identified three overlapping YAC clones, R7AC3, M659H5 and R14FC6, which is consistent with its location in close proximity to markers D22S947 and K54H5 in 22q11. Independently, we were also able to map an STS for the EST, D22S976E, to the same interval, and this EST turned out to correspond exactly to our cDNA clone.
CLH-22 shows strong similarity with the human clathrin heavy chain polypeptide gene, previously cloned from chromosome 17 (CLH-17) ( Fig. 2 and Table 1 ) (8, 9) . The overall identity and similarity between these two proteins is 84.7 and 91.1%, respectively. At the nucleic acid level, identity between the ORFs of both genes is 74.3% (Fig. 2) . Results from database searches for similarities with other previously cloned genes in human and other species are summarized in Table 1 . The level of similarities/ identities of the CLH-22 and CLH-17 genes to four clathrin heavy chain genes from lower species (D. melanogaster, C. elegans, D. discoideum, and S. cerevisiae) do not show striking differences. On filters A and D, numbers 1-8 correspond to heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas, respectively. Similarly, on filters B and E, numbers 1-8 correspond to spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes, respectively. On Northern blot with the mouse tissues (C), numbers 1-8 indicate heart, brain, spleen, lung, liver, skeletal muscle, kidney and testis, respectively. The position and estimated sizes of transcript bands are displayed on the left side of each filter. Two alternative transcript forms of the CLH-22 gene were detected in human testis (2.2 kb) and in peripheral blood leukocytes (5.5 kb). One alternative transcript form of the CLH-17 gene (2 kb) was detected in skeletal muscle. cfb4A, cfb4B and two PCR-derived probes specific for CLH-17 gene, amplified from human foetal brain and human adult skeletal muscle cDNA libraries, were used in the above experiments.
However, there is a clear discrepancy when both human clathrin heavy chain genes are compared to the bovine and rat genes. Our results suggest that counterparts of the CLH-17 gene have been cloned in these species, whereas presumptive mammalian homologues of CLH-22 gene are yet to be found.
Alternative splicing and expression patterns of two human clathrin heavy chain genes
A comparison of sequences from multiple cDNA clones originating from different cDNA libraries (see above) revealed that there exists one alternatively spliced transcript form, which is 171 bp shorter than the main product (Fig. 1, A3 ). Northern blot analysis (Fig. 3) revealed two other possible forms. Human peripheral blood leukocytes express a shorter (approximately 5-5.5 kb) transcript, with the apparent lack of the main form of the transcript present in all other tested tissues. It is unlikely that the above described alternatively spliced form missing 171 bp alone produces the mobility shift seen on Northern blot in RNA from human leukocytes. Therefore, other alternatively spliced exon(s) should exist. In human testis a third, approximately 2.2 kb long presumptive transcript form was observed. Another possible explanation regarding the 2.2 kb transcript is that it represents a novel gene. We studied transcript sizes and expression profiles of the CLH-22 and CLH-17 genes in 16 human tissues. When compared to CLH-17, CLH-22 displays a clearly shorter, approximately 6 kb transcript. Its expression is ubiquitous, consistent with its role as a housekeeping gene, although relatively low in all tissues except skeletal muscle, testis, and heart. It is extremely highly expressed in skeletal muscle, which we roughly estimate to 40-200 times higher than in the remaining 13 tissues. The CLH-17 gene is expressed at higher levels and evenly in all tissues tested (Fig. 3) . 
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Percentages of identity/similarity for cDNA sequence encompassing the entire ORF and translated polypeptide according to the longest ORF were calculated using the gap program from the GCG package. 
Analysis of the CLH-22 gene in meningiomas
We have earlier reported the β-adaptin gene (BAM22) localized in 22q12 as a candidate for meningioma tumor suppressor. This gene has been cloned from a small homozygous tumor deletion and lost its expression in 12% of sporadic meningiomas studied on Northern blots (16) . Furthermore, results from detailed deletion mapping of chromosome 22 in tumors failed to identify any single minimal overlapping region deleted in tumors, pointing to whole 22q as a candidate area harboring putative tumor suppressor gene(s) (17, 18) . Considering that CLH-22 may be a component in the same pathways of intracellular protein transport and signal transduction, as the BAM22 gene, we analysed expression of CLH-22 in 46 sporadic meningiomas on Northern blots prepared with total cellular RNA isolated from the tumors. Expression of CLH-22 could only be detected in nine cases (Fig. 4) (20) . We also investigated 82 sporadic meningiomas for detection of genomic rearrangements on available Southern blots prepared with TaqI, HincII, MspI, PvuII, and BglII. Each tumor and its corresponding constitutional tissue were present on one to three different Southern blots. Four tumors (5%) (Fig. 5 ) displayed an aberrant pattern of restriction fragments consistent with intragenic rearrangements of the CLH-22 gene. We used simultaneously three cDNA probes in these experiments: cfm4, cfb4A and cfb4B (Fig. 1B) , covering the entire ORF of the gene. Also here, tumors with (cases 141 and 149) and without (cases 36 and 118) large deletions of one copy of chromosome 22 displayed intragenic CLH-22 gene aberrations. Tumor 36 has previously shown a small deletion located in the vicinity of the telomere of chromosome 22, around marker KI-536 (D22S157) (18) . Upon investigation with CLH-22 probes one strong additional restriction fragment was observed in the tumor DNA and one larger fragment showed decreased autoradiographic intensity. These findings are consistent with the presence of a small, heterozygous, interstitial deletion in the tumor DNA. In tumors 118, 141 and 149, a loss of 1-4 restriction fragments was noted, consistent with presence of small interstitial homozygous deletions. The Southern blots used in this analysis were previously tested with multiple polymorphic and other probes for studies of chromosome 22 deletions in tumors (18) , allowing us to judge the quality of the filters with regard to partial restriction enzyme cleavage, equal amount of constitutional/tumor DNA loaded onto the gel, and no mis-pairing of samples. (18) . Tumor 143 is containing a terminal deletion of one copy of chromosome 22. It is not yet determined if this deletion encompasses the CLH-22 locus in 22q11. The breakpoints of the deletion were confined to the region between markers D22S24 and D22S10, which are flanking the CLH-22 gene on the centromeric and telomeric side, respectively (15, 18) . Analysis of Southern blot with tumor and constitutional DNA of tumor 149 revealed a homozygous loss of one band within the CLH-22 locus (Fig. 5) .
DISCUSSION
We report here molecular cloning of a novel, human clathrin heavy chain gene, which we localized to chromosome 22q11. The fact that two clathrin heavy chain genes exist at all, is an interesting and unexpected finding, and H. sapiens is so far the first species in which this has been shown. Clathrin heavy and light chain polypeptides together form three-armed structures called triskelions. It was believed that clathrin heavy chain polypeptides are uniform components of all clathrin coated vesicles (1, 2) . This unexpected diversity at the level of clathrin heavy chains raises the question as to what degree these two polypeptides are functionally interchangeable. Comparison of the amino acid sequences from CLH-17 and CLH-22 (Fig. 2) , shows that their overall amino acid similarity is high. It has previously been shown that two clathrin light chain genes exist in several Figure 5 . Southern blot analysis of CLH-22 gene on filters containing tumor (T) and constitutional (C) tissue from four patients (36, 118, 141, and 149) with meningiomas, which displayed evidence for intragenic rearrangements of CLH-22 gene. MspI, TaqI, and HincII were used to prepare the blots. In tumors 118, 141 and 149, one to four different DNA fragments (indicated by arrows) are homozygously lost in the tumor DNA. In tumor 36, no band displayed a total loss, but one extra fragment (2.5 kb) was detected, not seen in any other cases studied. The 3.5 kb fragment in this tumor also showed a decreased autoradiographic intensity. The tumor DNA from patient 36 could not be matched on the Southern blot shown in this figure with its corresponding constitutional tissue DNA. Constitutional tissue DNA from another patient, which displays the same pattern of bands as constitutional tissue DNA from case 36, is shown for comparison. Upon previous investigation (18) , tumors 36 and 118 (indicated by an asterisk) did not display large losses of heterozygosity on chromosome 22. In tumor 118 no area of deletion on chromosome 22 could be detected. In tumor 36 a small deletion was identified by one marker located in the vicinity of the telomere of 22q. Tumors 141 and 149 displayed monosomy 22. species (3) (4) (5) . It may be hypothesized that two different clathrin heavy chains participate in formation of distinct clathrin triskelions and which have partially or completely different functions in the intracellular receptor sorting and transport. Our findings of alternatively spliced forms of the CLH-22 gene are also new, as no alternative splicing has been shown to date for any other clathrin heavy chain genes. It will be important to characterize the entire genomic exon-intron structure of the gene, in parallel with a more detailed delineation of different alternatively spliced forms of CLH-22 in many tissues. Assuming that these splice variants reflect differences in protein function, they may be informative in helping to further understand the role of different domains of the protein. The strong variation in expression levels of the CLH-22 gene in human tissues is also surprising, especially when viewed in context of clearly uniform expression of the CLH-17 gene in the same set of human tissues studied on the same Northern blots (Fig. 3) . The high expression level in testis is unlikely to be unspecific, as no elevated levels of the CLH-17 gene expression was noted in the same tissue (Fig. 3) . Disruptions of clathrin heavy chain genes have been carried out in for instance D. melanogaster, and suggest that the clathrin heavy chain gene is essential in this organism. While most mutations of this gene in D. melanogaster are lethal, one allele has been described, which although not lethal, caused sterility in males (11) . The CLH-22 gene may therefore be important in an as yet not fully characterized process which is important for normal function of testis.
Clathrin triskelions interact with adaptor complexes, which is one of the main events during formation of the clathrin coated pits and vesicles. Two different adaptor complexes have been described; trans Golgi network adaptors and plasma membrane adaptors. Both adaptors are heterotetrameric protein complexes composed of γ-plus β′-and α-plus β-adaptins, respectively, as well as two additional smaller proteins. Because β-and β′-adaptins are the most homologous components of the adaptors it has been proposed that their main function is to interact with clathrin triskelions (2). It has also been shown that monomeric β-adaptins promote clathrin assembly in vitro (21) . Therefore, a documented functional link exists between clathrin and β-adaptins. We have previously characterized a human β′-adaptin gene from chromosome 22q12 (BAM22) and shown that this gene may be viewed as a candidate tumor suppressor gene involved in the development of meningioma (16) . In this context it should be emphasized that the CHL-22 gene also shows that it may be important in the tumor development and it is located within the region heterozygously deleted in up to 65% of meningiomas (18) . Our results call therefore for a full-scale screening of this gene for point mutations in meningiomas and in other malignancies which show specific deletions of chromosome 22. This analysis should be performed from tumor DNA as the starting material, since we have observed a frequent loss of the CLH-22 gene expression in meningiomas. This in turn, will necessitate characterization of the exon-intron borders for the entire CLH-22 gene. The large scale genomic sequencing of the CLH-22 gene region is well advanced (Z. Wang, G. Zhang, F. Chen, B. A. Roe, B. Emanuel and M. Budarf, personal communication). Our results from the CLH-22 gene expression on Northern blots with meningiomas also indicate that the CLH-22 promoter region should be studied for mutations affecting the elements controlling gene expression and a possible change of its methylation status.
MATERIALS AND METHODS
cDNA screening, Northern and Southern blot analysis
The following human cDNA libraries from Stratagene were used: fetal brain, polyT+ random primed, #936206; adult muscle, polyT primed, #937209; fetal muscle, polyT+ random primed, #836201. Approximately 600-800 000 plaques were plated for each screen (16) . In vivo excision of the cDNA clones were performed according to the recommendations of the supplier. Filters were hybridized and washed using stringent conditions (0.1× SSC, 0.1% SDS, 65_C) (22) . Northern blot analysis was performed as previously described (16, 17) . Two PCR-derived probes were designed for the CLH-17 gene, based on the sequence deposited in the databases (accession no. D21260) and amplified from the human spleen and placenta cDNA libraries using the following two pairs of primers: C17AU, TAA GAT GGA AGG AAA TGC; C17AL, TTA GCC CTT AGG TAC ACA; and C17BU, TGC TGA GAA ATG TAA TGC, C17BL, TCA GGA TCG TAG CAG TTG.
Genomic and cDNA sequencing, informatics
Cosmid DNA was prepared using Qiagen columns (QIAGEN, Inc.). Plasmid DNA was mini-prepared through alkaline lysis (22) . Plasmid inserts DNA and cosmid DNA was mechanically sheared using a nebulizer (IPI Medical Products, USA no. 4207) (23) . DNA fragments between 800-1500 bp were shot-gun cloned into pUC18 vector (Pharmacia). We used fluorescent end-labeled universal primers, or Taq Dye Deoxy Terminators (ABI). The sequences were assembled using the Staden program package (24) . Gaps in the shot-gun sequences were closed by primer walking strategy. Putative exonic sequences were predicted using the grail program (14) . Database searches and sequence comparisons were done using FastA and gap programs from Wisconsin Package, Genetics Computer Group, WI, USA. Repetitive sequences were filtered out using Pythia server (25) .
